Search

Theravance Biopharma Inc

Uždarymo kaina

16.91 -0.12

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

16.93

Max

16.93

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-66M

-4.9M

Pardavimai

-28M

18M

P/E

Sektoriaus vid.

7.565

68.51

Pelnas, tenkantis vienai akcijai

0.01

Pelno marža

-27.872

Darbuotojai

90

EBITDA

-24M

-5M

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

+0.41% upside

Dividendai

By Acuity

Kitas uždarbis

2026-08-11

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

3.2M

874M

Ankstesnė atidarymo kaina

17.03

Ankstesnė uždarymo kaina

16.91

Theravance Biopharma Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-08-09 23:52; UTC

Correlated Moves

The US 30Y Treasury Bond Index is trading lower, reaching its lowest point in a month amid cautious market sentiment and correlated asset declines.

2026-08-09 23:51; UTC

Bitcoin and Ethereum decline amid bearish sentiment, while U.S. labor data sparks record highs in equity markets and lowers Fed rate hike expectations.

2026-08-09 23:51; UTC

Singapore's markets closed for National Day; Japan's BOJ releases opinions, while China's inflation and PPI growth fall short of expectations, raising economic stability concerns.

2026-08-09 23:51; UTC

U.S. equity markets rally as disappointing July jobs data lowers Fed rate hike expectations, while Bitcoin and Ethereum decline amid cautious investor sentiment.

2026-08-09 23:51; UTC

Singapore's markets closed for National Day; Japan's monetary policy remains unclear while China's inflation drops to 0.5%, raising deflation concerns.

2026-08-09 23:51; UTC

Retail Sales Ex Autos Expected to Rise 0.2% in July Amid Mixed Economic Signals

2026-08-09 23:51; UTC

Japan's Q2 2026 GDP Growth Rate Release Expected at 0.5% Amid Mixed Market Sentiment and Geopolitical Concerns

2026-08-09 23:51; UTC

Japan's GDP Growth Forecasted at 0.02% for Q2 Amid Mixed Economic Sentiment and Global Uncertainties

2026-08-09 23:51; UTC

Correlated Moves

Bitcoin is trading lower during the session, reflecting cautious market sentiment amid slight declines in Ethereum and minimal hedge fund re-grossing in AI themes.

2026-08-09 23:41; UTC

BoJ Summary of Opinions Release Expected to Clarify Interest Rate Outlook Amidst Mixed Market Sentiment and Global Economic Trends.

2026-08-09 23:41; UTC

Japan's June current account data expected to show a significant surplus decline, raising concerns about economic challenges and impacting financial markets.

2026-08-09 23:41; UTC

U.S. Retail Sales Expected to Rise 0.1% in August Amid Cautious Consumer Sentiment and Economic Uncertainty

2026-08-09 23:31; UTC

Market Awaits July 2026 PPI Release Amid Mixed Inflation Signals and Potential Deflationary Pressures.

2026-08-09 23:31; UTC

Correlated Moves

Cardano is declining in today's session, continuing a downward trend observed since Saturday. The asset's movement reflects broader bearish sentiment in the market.

2026-08-09 23:21; UTC

Core Producer Prices Expected to Rise 0.2% Amid Slower Inflation and Cautious Investor Sentiment Ahead of August Release

2026-08-09 23:01; UTC

Palladium is trading lower during Sunday’s session, despite earlier gains. The asset remains above its 20-day moving average and near a one-month high.

2026-08-09 23:01; UTC

Silver has been gaining since Friday's close, currently above its 20-day moving average. The asset reached a session high before pulling back slightly.

2026-08-09 23:01; UTC

Silver/CAD is trading higher since Friday's close, reflecting a cumulative return of 0.17%. The price remains above its 20-day moving average.

2026-08-09 23:01; UTC

Gold/SGD is trading roughly flat, remaining above its 20-day moving average and near the upper end of its one-month range.

2026-08-09 23:01; UTC

Correlated Moves

Gold/NZD is trading higher, reflecting volatility earlier in the session. The asset remains above its 20-day moving average and near its one-month range's upper end.

2026-08-09 23:01; UTC

The US 2Y Treasury Bond Index is trading higher, remaining steady near the upper end of its one-month trading range. No specific news was identified.

2026-08-09 23:01; UTC

Correlated Moves

Gold/JPY is advancing, reflecting a positive trend since Friday's close. The asset remains above its 20-day moving average and near its one-month range high.

2026-08-09 23:01; UTC

Gold and silver are trading lower, continuing a downward trend since Friday's close. The assets briefly rebounded earlier in the session.

2026-08-09 23:01; UTC

Correlated Moves

Gold/GBP is trading roughly flat, influenced by a slight increase in Silver. Market sentiment remains cautious amid minimal hedge fund re-grossing within AI themes.

2026-08-09 23:01; UTC

Silver/NZD is higher today, maintaining a position above its 20-day moving average after pulling back from earlier session highs. No specific news was identified.

2026-08-09 23:01; UTC

Silver/JPY is trading higher today, maintaining a position above its 20-day moving average. The asset showed fluctuations earlier in the session.

2026-08-09 23:01; UTC

Silver/HKD is higher during Sunday’s session, continuing its positive momentum from Friday. The asset remains above its 20-day moving average.

2026-08-09 23:01; UTC

Correlated Moves

Gold/CHF is trading roughly flat, maintaining stability after a slight increase in correlation with silver amid cautious market sentiment and hedge fund activity.

2026-08-09 23:01; UTC

Silver/SGD is advancing during the ongoing session, remaining above its 20-day moving average and near the upper end of its one-month range.

2026-08-09 23:01; UTC

Gold/HKD is trading roughly flat, remaining 6.16% above its 20-day moving average and near the upper end of its one-month range.

Akcijų palyginimas

Kainos pokytis

Theravance Biopharma Inc Prognozė

Kainos tikslas

By TipRanks

0.41% į viršų

12 mėnesių prognozė

Vidutinis 17 USD  0.41%

Aukščiausias 17 USD

Žemiausias 17 USD

Remiantis 3 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Theravance Biopharma Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

3 ratings

0

Pirkti

3

Laikyti

0

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Theravance Biopharma Inc

Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States and Europe. It offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease (COPD). The company's product includes Ampreloxetine, an investigational norepinephrine reuptake inhibitor that has completed Phase III study for neurogenic orthostatic hypotension; and TRELEGY for the treatment of COPD and asthma. It has licensing and collaboration agreements with Pfizer Inc. for its preclinical skin-selective pan-JAK inhibitor program, as well as Viatris Inc. Theravance Biopharma, Inc. was incorporated in 2013 and is based in South San Francisco, California.
help-icon Live chat